The Ophthalmologist / Issues / 2026 / May / Texas First for Epioxa Therapy
Cornea Research & Innovations

Texas First for Epioxa Therapy

The first US rollout of FDA-approved epi-on cross-linking aims to improve comfort and recovery for keratoconus patients

5/6/2026 1 min read

Share

Related Content

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: